Recent News

 

46th SIMB Symposium

Mimetics presentation on using transcriptional analysis to improve biofuels and biomaterials production at the 46th SIMB Symposium  in Alexandria, VA, April 28, 2024.

Mimetics awarded DoE Phase I SBIR

Mimetics awarded DoE Phase I SBIR to develop transcriptional data analysis for advanced biofuels fermentations, February 15, 2024.

bioRxiv Preprint

bioRxiv preprint, J. Pritt et al, Synchronization of Human Circadian Blood Genes Between ex vivo and Cultured Blood Samples, January 23, 2024,      https://www.biorxiv.org/content/10.1101/2024.01.20.576368v1

Mimetics awarded NOAA SBIR

Mimetics awarded NOAA SBIR to develop novel yeast-based biosensor for bacterial pathogens, September 3, 2021.

Publication in PNAS

Publication in PNAS of work on circadian disruption in crop plants due to elevated nighttime temperatures in changing climate,  Jun  20, 2021, https://www.pnas.org/doi/full/10.1073/pnas.2025899118

Mimetics White Papers

Would you like to know more about Mimetics and our technology? Click through to the Mimetics Our Technology page where you will find two new white papers. Mimetics provides information on the ways in which Time-series Gene Expression Analysis can help in strain development and improving production processes and how our modeling tools help to quantify the strength of gene regulatory relationships. SEE MORE

Mimetics Awarded SBIR Grant from the NSF

/in /by

nsf1Mimetics is pleased to announce that it has been awarded a Phase I SBIR grant from the National Science Foundation (NSF). This award, which falls under the Computational Biology and Bioinformatics funding program, will assist us in two major ways. First it will help in the development of our newest software and algorithms that assist in analyzing gene expression data. Secondly,the SBIR will enhance our work into gene regulatory networks as well as a greater understanding of these critical networks that underlie so many biological processes.

Dr. Ashlee Valente Joins Mimetics

/in /by

Dr. Ashlee Valente is our newest hire at Mimetics. Dr. Valente earned her B.S. and M.S. in Bioinformatics at Rochester Institute in Technology and completed her doctoral studies at Duke University in Computational Biology and Bioinformatics. Ashlee’s doctoral thesis work focused on the development of statistical models to improve computational pre-processing of transcriptomics and proteomics data. During her postdoctoral work, Ashlee worked extensively on applied biomarker discovery. She has extensive experience building predictive models for clinical outcomes in infectious disease and biopolymer exposure in transcriptomics, proteomics, and metabolomics data. Dr. Valente brings with her an enthusiastic pursuit of leveraging this type of data via quantitative systems biology to advance understanding of biological mechanisms.

Mimetics to Collaborate with NCATS

/in /by

Mimetics is pleased to announce that it has teamed up with the National Center for Advancing Translational Science (NCATS). Our work with NCATS will be focused on the creation of new antibiotic screening protocols.

We are thrilled to move forward with a group that has been so committed to Translational Science and to “…turning observations in the laboratory, clinic and community into interventions that improve the health of individuals and the public.” (NCATS) and look forward to all that this collaboration produces.